Berry Genomics Co Ltd Class A 000710
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥7.04
- Day Range
- ¥7.01–7.17
- 52-Week Range
- ¥5.40–16.48
- Bid/Ask
- ¥7.05 / ¥7.06
- Market Cap
- ¥2.50 Bil
- Volume/Avg
- 3.9 Mil / 10.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.27
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,448
- Website
- http://www.berrygenomics.com
Comparables
Valuation
|
Metric
|
000710
|
688253
|
688068
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 19.67 | — |
Price/Book Value | 1.33 | 2.35 | 0.71 |
Price/Sales | 2.27 | 7.49 | 4.84 |
Price/Cash Flow | 23.76 | 11.35 | 12.45 |
Price/Earnings
000710
688253
688068
Financial Strength
|
Metric
|
000710
|
688253
|
688068
|
|---|---|---|---|
Quick Ratio | 1.63 | 10.60 | 2.87 |
Current Ratio | 2.02 | 11.04 | 6.20 |
Interest Coverage | — | 1,693.02 | — |
Quick Ratio
000710
688253
688068
Profitability
|
Metric
|
000710
|
688253
|
688068
|
|---|---|---|---|
Return on Assets (Normalized) | −13.01% | 12.17% | −3.97% |
Return on Equity (Normalized) | −18.59% | 13.13% | −4.25% |
Return on Invested Capital (Normalized) | −15.87% | 12.68% | −5.10% |
Return on Assets
000710
688253
688068
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Gchnfwxnj | Glcwb | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Vylyjnb | Jlqwzwk | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Hqwhpgdd | Wdhldm | $118.7 Bil | |||
| Moderna Inc
MRNA
| Xyfzbzhs | Qvby | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Zpzrmkz | Pwgps | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Bxtzjgpvk | Zjjc | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Rqwwzfksm | Kcnw | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Lbqvnzbv | Hkzql | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Wfpdyflx | Xks | $15.0 Bil | |||
| Incyte Corp
INCY
| Vkvcstj | Ctfsm | $13.5 Bil |